Literature DB >> 1033273

Caffeine in plasma and saliva by a radioimmunoassay procedure.

C E Cook, C R Tallent, E W Amerson, M W Myers, J A Kepler, G F Taylor, H D Christensen.   

Abstract

Caffeine was analyzed in human plasma and saliva by a simple, rapid, and sensitive radioimmunoassay procedure. Immunization of rabbits with an antigen prepared by coupling 7-(5-carboxypentyl)-1,3-dimethylxanthine to bovine serum albumin resulted in the formation of antibodies selective for caffeine as opposed to various mono- and dimethylxanthines, mono-, di-, and trimethyluric acids and a variety of common drugs. The radioligand used for competitive binding studies was 7-(2,3-3H2-propyl)-1,3-dimethylxanthine. The procedure permits direct analysis of caffeine in plasma or saliva without extraction. Comparison with a high pressure liquid chromatography method for the analysis of caffeine gave satisfactory results and showed no evidence for interference by metabolites. A caffeine half-life of 4.0 hours determined by the radioimmunoassay was in agreement with previous work. Comparison of human plasma and saliva levels by the radioimmunoassay procedure indicated approximately equal concentrations in the two fluids.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1033273

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  11 in total

Review 1.  Drug monitoring in nonconventional biological fluids and matrices.

Authors:  S Pichini; I Altieri; P Zuccaro; R Pacifici
Journal:  Clin Pharmacokinet       Date:  1996-03       Impact factor: 6.447

2.  Maturation of caffeine elimination in infancy.

Authors:  J V Aranda; J M Collinge; R Zinman; G Watters
Journal:  Arch Dis Child       Date:  1979-12       Impact factor: 3.791

3.  Salivary caffeine and neonatal behavior: assay modification and functional significance.

Authors:  E K Emory; S Konopka; S Hronsky; R Tuggey; R Davé
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

4.  Plasma and salivary pharmacokinetics of caffeine in man.

Authors:  R Newton; L J Broughton; M J Lind; P J Morrison; H J Rogers; I D Bradbrook
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

5.  Delayed elimination of caffeine by women in the last 2 weeks of pregnancy.

Authors:  W D Parsons; J G Pelletier
Journal:  Can Med Assoc J       Date:  1982-09-01       Impact factor: 8.262

6.  Salivary caffeine concentrations are comparable to plasma concentrations in preterm infants receiving extended caffeine therapy.

Authors:  Nicole R Dobson; Xiaoxi Liu; Lawrence M Rhein; Robert A Darnall; Michael J Corwin; Betty L McEntire; Robert M Ward; Laura P James; Catherine M T Sherwin; Timothy C Heeren; Carl E Hunt
Journal:  Br J Clin Pharmacol       Date:  2016-06-03       Impact factor: 4.335

7.  Menstrual cycle effects on caffeine elimination in the human female.

Authors:  J D Lane; J F Steege; S L Rupp; C M Kuhn
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

8.  Effect of pregnancy on the pharmacokinetics of caffeine.

Authors:  R Knutti; H Rothweiler; C Schlatter
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

9.  Salivary caffeine in Parkinson's disease.

Authors:  Giorgio Leodori; Maria Ilenia De Bartolo; Daniele Belvisi; Alessia Ciogli; Andrea Fabbrini; Matteo Costanzo; Simone Manetto; Antonella Conte; Claudio Villani; Giovanni Fabbrini; Alfredo Berardelli
Journal:  Sci Rep       Date:  2021-05-10       Impact factor: 4.379

10.  Pharmacokinetics of Caffeine following a Single Administration of Coffee Enema versus Oral Coffee Consumption in Healthy Male Subjects.

Authors:  Supanimit Teekachunhatean; Nisanuch Tosri; Noppamas Rojanasthien; Somdet Srichairatanakool; Chaichan Sangdee
Journal:  ISRN Pharmacol       Date:  2013-03-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.